2025-08-14 |
13F |
Susquehanna International Group, Llp
|
|
|
|
33 962 |
−90,30 |
381 |
−89,42 |
|
2025-08-14 |
13F |
Price T Rowe Associates Inc /md/
|
|
|
|
410 881 |
−0,18 |
5 |
0,00 |
|
2025-05-15 |
13F |
Paradigm Biocapital Advisors LP
|
|
|
|
0 |
−100,00 |
0 |
|
|
2025-06-26 |
NP |
USMIX - Extended Market Index Fund
|
|
|
|
3 633 |
−2,10 |
38 |
−24,49 |
|
2025-08-14 |
13F |
Polar Capital Holdings Plc
|
|
|
|
975 000 |
−7,14 |
10 930 |
1,45 |
|
2025-06-18 |
NP |
REBYX - U.S. Small Cap Equity Fund Class Y
|
|
Short
|
|
−1 036 |
−8,96 |
−11 |
−33,33 |
|
2025-08-12 |
13F |
Jefferies Financial Group Inc.
|
|
|
|
64 991 |
−83,95 |
729 |
−82,48 |
|
2025-05-15 |
13F |
Perceptive Advisors Llc
|
|
|
|
0 |
−100,00 |
0 |
−100,00 |
|
2025-08-14 |
13F |
Goldman Sachs Group Inc
|
|
|
|
72 249 |
−70,41 |
810 |
−67,70 |
|
2025-08-27 |
13F/A |
Squarepoint Ops LLC
|
|
|
|
0 |
−100,00 |
0 |
−100,00 |
|
2025-05-15 |
13F |
Great Point Partners Llc
|
|
|
|
0 |
−100,00 |
0 |
|
|
2025-08-15 |
13F |
Morgan Stanley
|
|
|
|
208 328 |
−60,53 |
2 335 |
−56,88 |
|
2025-05-14 |
13F |
Ensign Peak Advisors, Inc
|
|
|
|
0 |
−100,00 |
0 |
|
|
2025-05-15 |
13F |
Driehaus Capital Management Llc
|
|
|
|
0 |
−100,00 |
0 |
−100,00 |
|
2025-08-14 |
13F |
Artia Global Partners LP
|
|
|
|
0 |
−100,00 |
0 |
|
|
2025-08-13 |
13F |
Kennedy Capital Management, Inc.
|
|
|
|
64 926 |
−1,25 |
728 |
7,86 |
|
2025-08-19 |
NP |
RIFBX - U.S. Small Cap Equity Fund
|
|
|
|
0 |
−100,00 |
0 |
−100,00 |
|
2025-08-26 |
NP |
PRHSX - T. Rowe Price Health Sciences Fund, Inc.
|
|
|
|
257 030 |
−6,29 |
2 881 |
2,38 |
|
2025-05-15 |
13F |
Janus Henderson Group Plc
|
|
|
|
0 |
−100,00 |
0 |
|
|
2025-08-14 |
13F |
Wellington Management Group Llp
|
|
|
|
0 |
−100,00 |
0 |
|
|
2025-08-14 |
13F |
Boothbay Fund Management, Llc
|
|
|
|
19 003 |
−64,56 |
213 |
−61,27 |
|
2025-08-28 |
NP |
LYFCX - AlphaCentric LifeSci Healthcare Fund Class C
|
|
|
|
4 023 |
−18,13 |
45 |
−10,00 |
|
2025-05-15 |
13F |
Adage Capital Partners Gp, L.l.c.
|
|
|
|
0 |
−100,00 |
0 |
−100,00 |
|
2025-08-14 |
13F |
Occudo Quantitative Strategies Lp
|
|
|
|
0 |
−100,00 |
0 |
|
|
2025-08-13 |
13F |
ExodusPoint Capital Management, LP
|
|
|
|
0 |
−100,00 |
0 |
|
|
2025-08-14 |
13F |
Allostery Investments LP
|
|
|
|
0 |
−100,00 |
0 |
|
|
2025-08-13 |
13F |
OMERS ADMINISTRATION Corp
|
|
|
|
0 |
−100,00 |
0 |
|
|
2025-05-15 |
13F |
683 Capital Management, LLC
|
|
|
|
0 |
−100,00 |
0 |
|
|
2025-05-15 |
13F |
Aster Capital Management (DIFC) Ltd
|
|
|
|
0 |
−100,00 |
0 |
|
|
2025-08-14 |
13F |
Hrt Financial Lp
|
|
|
|
0 |
−100,00 |
0 |
|
|
2025-07-28 |
NP |
BIB - ProShares Ultra Nasdaq Biotechnology
|
|
|
|
1 377 |
−9,05 |
15 |
0,00 |
|
2025-03-28 |
NP |
DFAT - Dimensional U.S. Targeted Value ETF
|
|
|
|
0 |
−100,00 |
0 |
−100,00 |
|
2025-08-14 |
13F |
Point72 Asset Management, L.P.
|
|
|
|
330 000 |
−3,62 |
3 699 |
5,29 |
|
2025-08-14 |
13F |
Man Group plc
|
|
|
|
0 |
−100,00 |
0 |
|
|
2025-08-14 |
13F |
Millennium Management Llc
|
|
|
|
12 326 |
−77,23 |
138 |
−75,14 |
|
2025-04-28 |
NP |
John Hancock Funds II - Health Sciences Fund Class NAV
|
|
|
|
4 677 |
−43,62 |
47 |
−73,89 |
|
2025-08-14 |
13F |
Qube Research & Technologies Ltd
|
|
|
|
0 |
−100,00 |
0 |
|
|
2025-08-14 |
13F |
Ikarian Capital, LLC
|
|
|
|
68 574 |
−60,81 |
769 |
−57,21 |
|
2025-08-13 |
13F |
Renaissance Technologies Llc
|
|
|
|
13 900 |
−61,17 |
156 |
−57,77 |
|
2025-07-31 |
13F |
Quest Partners LLC
|
|
|
|
16 064 |
−1,66 |
180 |
7,78 |
|
2025-08-12 |
13F |
Coldstream Capital Management Inc
|
|
|
|
0 |
−100,00 |
0 |
|
|
2025-08-14 |
13F |
Redmile Group, LLC
|
|
|
|
0 |
−100,00 |
0 |
|
|
2025-07-24 |
NP |
FSKAX - Fidelity Total Market Index Fund
|
|
|
|
58 135 |
−2,47 |
637 |
5,29 |
|
2025-08-14 |
13F |
Braidwell Lp
|
|
|
|
1 524 842 |
−3,03 |
17 093 |
5,95 |
|
2025-05-14 |
13F |
Jane Street Group, Llc
|
|
|
|
0 |
−100,00 |
0 |
|
|
2025-08-14 |
13F |
Group One Trading, L.p.
|
|
|
|
0 |
−100,00 |
0 |
−100,00 |
|
2025-07-29 |
13F |
Cannon Global Investment Management, LLC
|
|
|
|
0 |
−100,00 |
0 |
|
|